Muscarinic, N-methyl-D-aspartate (NMDA) and benzodiazepine receptor binding sites in cortical membranes from amyotrophic lateral sclerosis patients

Journal of the Neurological Sciences

Volumn 143, Issue 1-2, 1996, Pages 121-125

  Gredal, Ole ^a   Pakkenberg, Bente ^b   Nielsen, Mogens ^a  

^a Sct Hans Hospital   (Denmark)

^b Kommunehospitalet ^*  (Denmark)

Author keywords

Amyotrophic lateral sclerosis; Benzodiazepine receptor; Cortex; Motor cortex; Muscarinic receptor; NMDA receptor; Receptor binding

Indexed keywords

BENZODIAZEPINE RECEPTOR; DIZOCILPINE; FLUMAZENIL; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINUCLIDINYL BENZILATE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BINDING SITES; BRAIN CHEMISTRY; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FLUMAZENIL; GABA MODULATORS; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; MUSCARINIC ANTAGONISTS; QUINUCLIDINYL BENZILATE; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; RECEPTORS, MUSCARINIC; RECEPTORS, N-METHYL-D-ASPARTATE; TRITIUM;

EID: 0030296379     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00196-7     Document Type: Article

References (26)

1. Allaoua H., Chaudieu I., Krieger C., Boksa P., Privat A., Quirion R. Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients. Brain Res. 579:1992;169-172.
2. Berger M.L., Veitl M., Malessa S., Sluga E., Hornykiewicz O. Cholinergic markers in ALS spinal cord. J. Neurol. Sci. 108:1992;114-117.
3. Braendgaard H., Evans S.M., Howard C.V., Gundersen H.J. The total number of neurons in the human neocortex unbiasedly estimated using optical disectors. J. Microsc. 157:1990;285-304.
4. Foster A.C., Wong E.H. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br. J. Pharmacol. 91:1987;403-409.
5. Gillberg P.G., Aquilonius S.M. Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography. Changes in amyotrophic lateral sclerosis. Acta Neurol. Scand. 72:1985;299-306.
6. Hayashi H., Suga M., Satake M., Tsubaki T. Reduced glycine receptor in the spinal cord in amyotrophic lateral sclerosis. Ann. Neurol. 9:1981;292-294.
7. Hubbard C.M., Redpath G.T., Macdonald T.L., VandenBerg S.R. Modulatory effects of aluminum, calcium, lithium, magnesium, and zinc ions on [3H]MK-801 binding in human cerebral cortex. Brain Res. 486:1989;170-174.
8. Kornhuber J., Mack Burkhardt F., Kornhuber M.E., Riederer P. [3H]MK-801 binding sites in post-mortem human frontal cortex. Eur. J. Pharmacol. 162:1989;483-490.
9. Krieger C., Wagey R., Shaw C. Amyotrophic lateral sclerosis: quantitative autoradiography of [3H]MK-801/NMDA binding sites in spinal cord. Neurosci. Lett. 159:1993;191-194.
10. Krieger C., Wagey R., Lanius R.A., Shaw C.A. Activation of PKC reverses apparent NMDA receptor reduction in ALS. Neuroreport. 4:1993;931-934.
11. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
12. Möhler H., Richards J.G. Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature. 294:1981;763-765.
13. Perry T.L., Krieger C., Hansen S., Eisen A. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann. Neurol. 28:1990;12-17.
14. Piggott M.A., Perry E.K., Sahgal A., Perry R.H. Examination of parameters influencing [3H]MK-801 binding in postmortem human cortex. J. Neurochem. 58:1992;1001-1008.
15. Plaitakis A., Caroscio J.T. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 22:1987;575-579.
16. Procter A.W., Wong E.H., Stratmann G.C., Lowe S.L., Bowen D.M. Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease. J. Neurochem. 53:1989;698-704.
17. Ransom R.W., Stec N.L. Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J. Neurochem. 51:1988;830-836.
18. Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28:1990;18-25.
19. Rothstein J.D., Martin L.J., Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326:1992;1464-1468.
20. Rothstein J.D., Kuncl R.W. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65:1995;643-651.
21. Shaw P.J., Ince P.G., Matthews J.N., Johnson M., Candy J.M. N-methyl-D-aspartate (NMDA) receptors in the spinal cord and motor cortex in motor neuron disease: a quantitative autoradiographic study using [3H]MK-801. Brain Res. 637:1994;297-302.
22. Sheng M., Cummings J., Roldan L.A., Jan Y.N., Jan L.Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature. 368:1994;144-147.
23. Steele J.E., Robinson T.N., Cross A.J., Bowen D.M., Green A.R. A comparison of [3H]MK-801 and N-[1-(2-thienyl)cyclohexyl]-3,4-[3H]piperidine binding to the N-methyl-D-aspartate receptor complex in human brain. J. Neurochem. 56:1991;1248-1254.
24. Vanderheyden P., Gies J.P., Ebinger G., De Keyser J., Landry Y., Vauquelin G. Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists. J. Neurol. Sci. 97:1990;67-80.
25. Whitehouse P.J., Wamsley J.K., Zarbin M.A., Price D.L., Tourtellotte W.W., Kuhar M.J. Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors. Ann. Neurol. 14:1983;8-16.
26. Witt M.R., Nielsen M. Characterization of the influence of unsaturated free fatty acids on brain GABA/benzodiazepine receptor binding in vitro. J. Neurochem. 62:1994;1432-1439.